- Home
- JXJT vs BMRA Comparison
JXJT vs BMRA Comparison
Compare JXJT & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXJT
- BMRA
- Stock Information
- Founded
- JXJT 2012
- BMRA 1971
- Country
- JXJT China
- BMRA United States
- Employees
- JXJT N/A
- BMRA N/A
- Industry
- JXJT Apparel
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- JXJT Consumer Staples
- BMRA Health Care
- Exchange
- JXJT Nasdaq
- BMRA Nasdaq
- Market Cap
- JXJT 11.5M
- BMRA 7.4M
- IPO Year
- JXJT 2012
- BMRA N/A
- Fundamental
- Price
- JXJT $1.57
- BMRA $0.32
- Analyst Decision
- JXJT
- BMRA
- Analyst Count
- JXJT 0
- BMRA 0
- Target Price
- JXJT N/A
- BMRA N/A
- AVG Volume (30 Days)
- JXJT 36.7K
- BMRA 68.2K
- Earning Date
- JXJT 11-01-2024
- BMRA 10-15-2024
- Dividend Yield
- JXJT N/A
- BMRA N/A
- EPS Growth
- JXJT N/A
- BMRA N/A
- EPS
- JXJT 0.48
- BMRA N/A
- Revenue
- JXJT $31,840,588.00
- BMRA $5,509,000.00
- Revenue This Year
- JXJT N/A
- BMRA N/A
- Revenue Next Year
- JXJT N/A
- BMRA N/A
- P/E Ratio
- JXJT $3.40
- BMRA N/A
- Revenue Growth
- JXJT N/A
- BMRA 1.74
- 52 Week Low
- JXJT $1.04
- BMRA $0.24
- 52 Week High
- JXJT $8.51
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- JXJT 38.73
- BMRA 47.45
- Support Level
- JXJT $1.40
- BMRA $0.28
- Resistance Level
- JXJT $1.75
- BMRA $0.35
- Average True Range (ATR)
- JXJT 0.14
- BMRA 0.03
- MACD
- JXJT -0.04
- BMRA 0.00
- Stochastic Oscillator
- JXJT 32.08
- BMRA 38.50
About JXJT JX Luxventure Limited
JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.